Photosensitisers for photodynamic therapy: State of the art and perspectives

Título traducido de la contribución: Photosensitisers for photodynamic therapy: State of the art and perspectives

Beatriz Rodríguez Amigo, Oriol Planas Marques, Roger Bresoli Obach, Joaquim Torra Nonell, Ruben Ruiz Gonzalez, Santiago Nonell Marrugat

Producción científica: Capítulo del libroCapítulo

Resumen

Photodynamic therapy relies on the action of a photosensitising drug in order to generate reactive oxygen species that cause damage to biological cells and tissues. The key aspects for the success of this therapy are the optical and photosensitising properties of the drug, as well as its pharmacological properties. This chapter provides an overview of the drugs already approved for clinical use for cancer, antimicrobial or other applications, as well as a list of those in clinical trials and at the preclinical stage. Emerging strategies for controlling the production of reactive oxygen species and novel photosensitising modalities brought about by the bio- and nano-revolutions are discussed.
Título traducido de la contribuciónPhotosensitisers for photodynamic therapy: State of the art and perspectives
Idioma originalInglés
Título de la publicación alojadaPhotodynamic Medicine: From bench to clinic
EditoresHerwig Kostron, Tayyaba Hasan
EditorialRoyal Society of Chemistry
Capítulo2
Páginas23-62
Número de páginas39
ISBN (versión digital)978-1-78262-823-1, 978-1-78262-682-4
ISBN (versión impresa)978-1-78262-451-6
DOI
EstadoPublicada - 2016

Serie de la publicación

NombreComprehensive Series in Photochemical & Photobiological Sciences
ISSN (versión impresa)2041-9716
ISSN (versión digital)2041-9724

Huella

Profundice en los temas de investigación de 'Photosensitisers for photodynamic therapy: State of the art and perspectives'. En conjunto forman una huella única.

Citar esto